Sales and Marketing

Showing 15 posts of 11527 posts found.

Doctors.net.uk appoints Gareth Thomas

June 14, 2010 Medical Communications, Sales and Marketing appointment, doctors.net, medical communications, sales and marketing

Gareth Thomas has joined UK online medical professional network Doctors.net.uk as international development director.

Implementing value-based pricing in the UK

June 14, 2010 Sales and Marketing hta, pricing, value

The UK has a strong history of innovation in medicines and it is vital to the economy that this continues …

GSK acquires Argentine pharma firm

June 11, 2010 Sales and Marketing Argentina, GlaxoSmithKline, Latin America, em

GlaxoSmithKline has acquired a leading Argentine pharma firm Laboratorios Phoenix in a move to make further inroads into Latin America. …

Gilenia on track to become first oral MS drug

June 11, 2010 Sales and Marketing Gilenia, MS

Novartis’ oral MS therapy Gilenia has been boosted by an FDA committee’s unanimous recommendation for its approval. The drug is …

The Research Partnership makes global appointments

June 11, 2010 Sales and Marketing The Research Partnership, appointment, sales and marketing

Market research firm The Research Partnership has made two appointments to its global network of offices. Philippe Pouliot has been …

Zactima promising in rare thyroid cancer

June 11, 2010 Research and Development, Sales and Marketing AstraZeneca, thyroid cancer, zactima

AstraZeneca’s Zactima (vandetanib) will be filed with regulators later this year as a treatment for thyroid cancer after promising results. …

Genzyme and Icahn agree compromise deal

June 10, 2010 Research and Development, Sales and Marketing Genzyme

Carl Icahn has won his battle with Genzyme to have his associates given a place on the company’s board.The US …

NICE rejects GSK’s Revolade

June 10, 2010 Sales and Marketing ITP, NICE, Revolade

NICE has rejected GlaxoSmithKline’s Revolade saying in draft guidance that the blood disorder drug’s benefits were unclear. The watchdog assessed …

NICE says no to GSK breast cancer drug

June 10, 2010 Sales and Marketing NICE, Tyverb

NICE has issued final draft guidance restricting use of GlaxoSmithKline’s breast cancer drug Tyverb to clinical trials, citing high cost …

EU regulators to assess potential lupus breakthrough drug

June 8, 2010 Sales and Marketing Benlysta, Human Genome Sciences, Lupus

GlaxoSmithKline and Human Genome Sciences have submitted a marketing application to the European Medicines Agency for their new lupus drug. …

CME Spotlight: Power to the people

June 8, 2010 Medical Communications, Sales and Marketing CME Spotlight, transparency

The UK general election is now over and as we stayed up to watch the count, or woke on the …

EMA under fire for blocking data access

June 8, 2010 Research and Development, Sales and Marketing Acomplia, Alli, EMA, Xenical, data

The European ombudsman has called for the European Medicines Agency to grant access to clinical study reports and trial protocols …

Digital Pharma: Novo Nordisk’s online ethics tools

June 8, 2010 Medical Communications, Sales and Marketing Novo Nordisk, compliance, ethics

Two new e-learning tools have been launched to help shed some light on ethical grey areas and give individuals a …

Idis appoints Richard Greatorex

June 8, 2010 Research and Development, Sales and Marketing IDIS, appointment, research and development, sales and marketing

Richard Greatorex has joined specialist medicines supplies company Idis as international marketing manager for its global headquarters in the UK. …

AZ submits Nexium-aspirin combination for EU approval

June 7, 2010 Sales and Marketing AstraZeneca, Nexium, aspirin

AstraZeneca is seeking European approval for a new version of its anti-ulcer blockbuster Nexium that combines the pill with aspirin. …
The Gateway to Local Adoption Series

Latest content